CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Anhui Anke Biotechnology (Group) Company., Limited Company Snapshot
Anhui Anke Biotechnology (Group) Company., Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Anhui Anke Biotechnology (Group) Company., Limited with three other companies in this sector in China: Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (2016 sales of 849.33 million Chinese Renmimbi [US$124.35 million] of which 100% was Medicine Product), Tianjin Lisheng Pharmaceutical Company Limited (846.83 million Chinese Renmimbi [US$123.98 million] of which 100% was Phamaceutical Manufacturing), and Hybio Pharmaceutical Co Ltd (855.05 million Chinese Renmimbi [US$125.19 million] of which 100% was Medical and Pharmaceutical Manufacturing).

Sales Analysis. During the year ended December of 2016, sales at Anhui Anke Biotechnology (Group) Company., Limited were 849.19 million Chinese Renmimbi (US$124.33 million). This is an increase of 33.6% versus 2015, when the company's sales were 635.70 million Chinese Renmimbi. This was the fifth consecutive year of sales increases at Anhui Anke Biotechnology (Group) Company., Limited (and since 2011, sales have increased a total of 217%). Sales of Others saw an increase that was more than double the company's growth rate: sales were up 534.8% in 2016, from 1.87 million Chinese Renmimbi to 11.87 million Chinese Renmimbi. Not all segments of Anhui Anke Biotechnology (Group) Company., Limited experienced an increase in sales in 2016: sales of Medical Services fell 75.2% to 1.94 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales). Anhui Anke Biotechnology (Group) Company., Limited also experienced decreases in sales in Chemical Synthetic Drugs (down 0.4% to 104.64 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Anhui Anke Biotechnology (Group) Company., Limited
  Stock Performance Chart for Anhui Anke Biotechnology (Group) Company., Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (6/23/2017): 16.05
(Figures in Chinese Renmimbi)
1 Week 0.3%   13 Weeks 4.2%  
4 Weeks -2.5%   52 Weeks -22.4%  
 
Anhui Anke Biotechnology (Group) Company., Limited Key Data:
  Ticker: 300009 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 849,189,537
(Year Ending Jan 2017).
Employees: 1,546
  Currency: Chinese Renmimbi Market Cap: 11,425,699,372
  Fiscal Yr Ends: December Shares Outstanding: 711,881,581
  Share Type: A Gu Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.